SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 33.77
+1.05 (3.21%)
At close: Oct 30, 2026
SMO ClinPlus CO.,LTD. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,668 | 4,111 | 2,144 | 3,884 | 2,922 | - | |
Market Cap Growth | -35.33% | 91.81% | -44.81% | 32.91% | - | - |
Enterprise Value | 2,120 | 3,475 | 1,274 | 3,000 | 2,179 | - |
Last Close Price | 33.77 | 51.95 | 26.78 | 48.09 | 36.19 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 93.42 | 37.50 | 20.14 | 28.83 | 40.35 | - |
Forward PE | - | 37.71 | 17.34 | 26.00 | - | - |
PS Ratio | 3.25 | 4.88 | 2.67 | 5.11 | 4.98 | - |
PB Ratio | 2.10 | 3.24 | 1.83 | 3.59 | 3.07 | - |
P/TBV Ratio | 2.10 | 3.24 | 1.83 | 3.60 | 3.07 | - |
P/FCF Ratio | - | 147.57 | - | 37.13 | 89.95 | - |
P/OCF Ratio | - | 115.19 | - | 33.82 | 72.26 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.59 | 4.13 | 1.59 | 3.95 | 3.72 | - |
EV/EBITDA Ratio | 55.55 | 30.46 | 12.81 | 22.21 | 30.14 | - |
EV/EBIT Ratio | 95.96 | 32.27 | 13.63 | 22.98 | 31.70 | - |
EV/FCF Ratio | - | 124.74 | - | 28.68 | 67.07 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.06 | 0.04 | 0.06 | 0.08 | 0.06 | 0.06 |
Debt / FCF Ratio | - | 0.16 | - | 0.11 | 0.13 | 0.13 |
Net Debt / Equity Ratio | -0.43 | -0.48 | -0.75 | -0.84 | -0.85 | -0.57 |
Net Debt / EBITDA Ratio | -19.03 | -5.37 | -8.88 | -6.69 | -11.20 | -1.86 |
Net Debt / FCF Ratio | 14.14 | -22.01 | 85.80 | -8.64 | -24.92 | -3.53 |
Asset Turnover | 0.54 | 0.57 | 0.57 | 0.60 | 0.75 | 1.45 |
Quick Ratio | 4.84 | 4.82 | 5.43 | 4.72 | 5.43 | 2.16 |
Current Ratio | 4.86 | 4.83 | 5.43 | 4.72 | 5.43 | 2.17 |
Return on Equity (ROE) | 2.35% | 8.98% | 9.45% | 13.26% | 12.26% | 29.34% |
Return on Assets (ROA) | 0.91% | 4.53% | 4.18% | 6.46% | 5.49% | 12.20% |
Return on Invested Capital (ROIC) | 2.19% | 19.52% | 35.00% | 68.32% | 51.22% | 72.95% |
Return on Capital Employed (ROCE) | 1.70% | 8.50% | 8.00% | 12.00% | 7.20% | 29.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.07% | 2.67% | 4.96% | 3.47% | 2.48% | - |
FCF Yield | -1.45% | 0.68% | -0.48% | 2.69% | 1.11% | - |
Dividend Yield | 0.44% | 0.28% | 0.93% | 0.37% | 0.22% | - |
Payout Ratio | 39.43% | 12.15% | 20.75% | 7.98% | - | - |
Buyback Yield / Dilution | 6.95% | -0.78% | -0.06% | -11.32% | -20.98% | - |
Total Shareholder Return | 7.39% | -0.49% | 0.87% | -10.95% | -20.76% | - |